Skip to content
Baret News – Lifestyle
Author:
XORTX Therapeutics Inc.
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
June 12, 2026
XORTX Meets Nasdaq Continued Listing Requirements
April 21, 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
April 14, 2026
XORTX Announces Results of Annual and Special Meeting of Shareholders
March 27, 2026
XORTX Announces Share Consolidation
March 25, 2026
XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting
March 24, 2026
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders
March 18, 2026
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation
March 13, 2026
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
March 5, 2026